François Meurice

1 ta ish

GlaxoSmithKline (United Kingdom)

1. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study

   Timo Vesikari, Aino Karvonen, Roman Prymula +7

   Maqola20072 iqtibos

   ABIABI:AkademIndex/2026.other.359383